The Stocks Wall Street Is Watching
The following stocks may be
impacted due to significant news as noted:
Drug stocks are in the news, as Abbott Labs
(
ABT |
Quote |
Chart |
News |
PowerRating)
has been downgraded by Morgan Stanley to “equal-weight” from “overweight”.
Bar Labs
(
BRL |
Quote |
Chart |
News |
PowerRating) is likely to benefit from an upgrade by Salomon Smith
Barney to the specialty pharmaceutical who now rates it a “market weight” from a
previous “underweight”. Forrest Labs
(
FRX |
Quote |
Chart |
News |
PowerRating) has announced positive
Phase III results for its Alzeimer therapy. Also, Johnson & Johnson
(
JNJ |
Quote |
Chart |
News |
PowerRating)
has announced positive results for its drug Risperdal, used to treat people
diagnosed as bipolar.
Defense contractor Northrop Grumman
(
NOC |
Quote |
Chart |
News |
PowerRating)
has reached a deal with the Justice Dept. that will allow it to acquire TRW
Inc.
(
TRW |
Quote |
Chart |
News |
PowerRating), given the approval of shareholders from both companies.
Broadcasting and cable TV company Emmis
Communications
(
EMMS |
Quote |
Chart |
News |
PowerRating) has been downgraded by Morgan Stanley to
“underweight” from “equal-weight”.